Physician

Gregory Ashton Edwards, M.D.

According to 2025 Medicare claims, Gregory Edwards, M.D. (NPI: 1700853793) practices urology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 75605-5205. Edwards is affiliated with the CHSPSC ACO 8, LLC (ACO ID: A3715), participating under the MSSP model.

Edwards' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 680 traditional Medicare patients, billed 9,833 HCPCS/CPT codes, and received $245,073 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,329 prescription claims across 739 beneficiaries totaling $454,615 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 11 claims. Open Payments data shows 32 records totaling $962. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $233,000 to $454,615. In contrast, DME billing represents a smaller volume and declined steadily, from $618 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	831	23,976	$288,679
2016	791	20,571	$269,528
2017	804	34,652	$234,404
2018	752	24,417	$195,446
2019	695	18,583	$186,694
2020	665	22,122	$191,511
2021	686	27,834	$237,155
2022	693	26,126	$217,261
2023	675	26,079	$211,920
2024	680	9,833	$245,073

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	541	2,529	$233,000
2016	530	2,634	$228,814
2017	565	2,850	$305,016
2018	555	2,828	$307,709
2019	566	2,881	$314,523
2020	565	2,847	$295,343
2021	636	2,996	$309,704
2022	623	2,941	$329,620
2023	663	2,992	$403,748
2024	739	3,329	$454,615

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	52	$36,414
2016	N/R	73	$43,877
2017	N/R	73	$22,481
2018	N/R	75	$53,140
2019	N/R	47	$12,625
2020	N/R	26	$12,185
2021	N/R	52	$49,240
2022	N/R	69	$37,433
2023	N/R	24	$8,164
2024	N/R	11	$88

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	443	776	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	247	330	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	384	579	$12
36415	Insertion of needle into vein for collection of blood sample	294	459	$9
81001	Manual urinalysis test with examination using microscope, automated	592	1,173	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	282	12,279	$183,445
Gemtesa	Vibegron	268	11,409	$178,596
Mirabegron Er	Mirabegron	31	2,086	$19,051
Tamsulosin Hcl	Tamsulosin Hcl	1,013	72,907	$15,807
Silodosin	Silodosin	114	6,325	$8,284

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	11	$88

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$962	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gregory Ashton Edwards, M.D.?

Tedicare shows public-source Medicare data for Gregory Ashton Edwards, M.D. (NPI 1700853793), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory Ashton Edwards, M.D. have ACO affiliation data?

Gregory Ashton Edwards, M.D. is shown with ACO affiliation data for CHSPSC ACO 8, LLC (MSSP, ACO ID A3715).

What billing organization is linked to Gregory Ashton Edwards, M.D.?

Gregory Ashton Edwards, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Gregory Ashton Edwards, M.D. have Open Payments data?

Gregory Ashton Edwards, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.